William Watson

Has grant

Full Professor of Cancer Biology

Dublin City University

Ireland

Research Interests

Explore related searches

Professors in Ireland Professors in Medical Imaging Medical Imaging professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William Watson is a Full Professor of Cancer Biology at University College Dublin, Ireland. His research focuses on prostate cancer diagnosis and treatment, with recent articles exploring the efficacy of biomarkers, the role of histone deacetylase inhibitors, and machine learning applications in cancer detection. He is actively involved in integrating serum biomarkers into predictive models for biochemical recurrence and investigating the biology of cancer through advanced profiling techniques.

Recent Grants

Grant: Close

Validation and Risk Calculator Integration of Novel Biomarkers for Detection of Prostate Cancer

Open Date: 2017-01-01

Close Date: 2018-10-01

Grant: Close

Building a risk calculator to inform prostate cancer diagnosis

Open Date: 2016-12-01

Close Date: 2019-08-01

Grant: Close

Optimal Management of Gender-Specific Cancers via Efficient Use of Protein Profiling, Digital Pathology and Systems Medicine Tools (OPTi-PREDICT)

Open Date: 2016-09-01

Close Date: 2020-10-01

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

IRELAND

View details

Helmut Klocker

Head of the Division of Experimental Urology

Medical University of Innsbruck

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Watson

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor

Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy.

Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer.

Feature fusion of Raman chemical imaging and digital histopathology using machine learning for prostate cancer detection.

Integrating inflammatory serum biomarkers into a risk calculator for prostate cancer detection.

Prostate Cancer Diagnosis in the Clinic Using an 8-Protein Biomarker Panel.

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling.

Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer.

A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort.

The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.

Collaborators (12)

Breandan Kennedy

Desmond J. Tobin

Laura Gorman

Amirhossein Jalali

Shirin Moghaddam

Helmut Klocker

Kayleigh Slater

Susan Mckeever

John Crown

Paul Conroy

Thomas Brendan Murphy

Orla Sheils

Make your next move.